Neuland Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Neuland Laboratories has a total shareholder equity of ₹14.0B and total debt of ₹941.5M, which brings its debt-to-equity ratio to 6.7%. Its total assets and total liabilities are ₹19.4B and ₹5.5B respectively. Neuland Laboratories's EBIT is ₹3.5B making its interest coverage ratio -5315.1. It has cash and short-term investments of ₹1.9B.
Key information
6.7%
Debt to equity ratio
₹941.46m
Debt
| Interest coverage ratio | -5315.1x |
| Cash | ₹1.90b |
| Equity | ₹13.95b |
| Total liabilities | ₹5.49b |
| Total assets | ₹19.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524558's short term assets (₹9.7B) exceed its short term liabilities (₹4.1B).
Long Term Liabilities: 524558's short term assets (₹9.7B) exceed its long term liabilities (₹1.4B).
Debt to Equity History and Analysis
Debt Level: 524558 has more cash than its total debt.
Reducing Debt: 524558's debt to equity ratio has reduced from 28.1% to 6.7% over the past 5 years.
Debt Coverage: 524558's debt is well covered by operating cash flow (261%).
Interest Coverage: 524558 earns more interest than it pays, so coverage of interest payments is not a concern.